Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.
about
Differentiated Thyroid Cancer-Treatment: State of the Art.Blocking type TSH receptor antibodies.N-Glycoprofiling Analysis for Carbohydrate Composition and Site-Occupancy Determination in a Poly-Glycosylated Protein: Human Thyrotropin of Different Origins.Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH.
P2860
Acta Oncologica Lecture. Present status of the use of recombinant human TSH in thyroid cancer management.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@en
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@nl
type
label
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@en
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@nl
prefLabel
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@en
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@nl
P2860
P1433
P1476
Acta Oncologica Lecture. Prese ...... in thyroid cancer management.
@en
P2093
Markus Luster
P2860
P304
P356
10.1080/02841860600979013
P577
2006-01-01T00:00:00Z